BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

645 related articles for article (PubMed ID: 17488792)

  • 1. Heterozygous mutation of steroidogenic factor-1 in 46,XY subjects may mimic partial androgen insensitivity syndrome.
    Coutant R; Mallet D; Lahlou N; Bouhours-Nouet N; Guichet A; Coupris L; Croué A; Morel Y
    J Clin Endocrinol Metab; 2007 Aug; 92(8):2868-73. PubMed ID: 17488792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testicular dysgenesis without adrenal insufficiency in a 46,XY patient with a heterozygous inactive mutation of steroidogenic factor-1.
    Hasegawa T; Fukami M; Sato N; Katsumata N; Sasaki G; Fukutani K; Morohashi K; Ogata T
    J Clin Endocrinol Metab; 2004 Dec; 89(12):5930-5. PubMed ID: 15579739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update--steroidogenic factor 1 (SF-1, NR5A1).
    Köhler B; Achermann JC
    Minerva Endocrinol; 2010 Jun; 35(2):73-86. PubMed ID: 20595937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel mutation (c.2735_2736delTC) in the androgen receptor gene in 46,XY females with complete androgen insensitivity syndrome in an Egyptian family.
    Mazen I; Soliman H; El-Gammal M; Torky A; Mekkawy M; Abdel-Hamid MS; Essawi M
    Horm Res Paediatr; 2014; 82(6):411-4. PubMed ID: 25034089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical, hormonal and genetic characteristics of androgen insensitivity syndrome in 39 Chinese patients.
    Liu Q; Yin X; Li P
    Reprod Biol Endocrinol; 2020 Apr; 18(1):34. PubMed ID: 32345305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterozygous missense mutations in steroidogenic factor 1 (SF1/Ad4BP, NR5A1) are associated with 46,XY disorders of sex development with normal adrenal function.
    Lin L; Philibert P; Ferraz-de-Souza B; Kelberman D; Homfray T; Albanese A; Molini V; Sebire NJ; Einaudi S; Conway GS; Hughes IA; Jameson JL; Sultan C; Dattani MT; Achermann JC
    J Clin Endocrinol Metab; 2007 Mar; 92(3):991-9. PubMed ID: 17200175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of gonadal function in 107 intersex patients by means of serum antimüllerian hormone measurement.
    Rey RA; Belville C; Nihoul-Fékété C; Michel-Calemard L; Forest MG; Lahlou N; Jaubert F; Mowszowicz I; David M; Saka N; Bouvattier C; Bertrand AM; Lecointre C; Soskin S; Cabrol S; Crosnier H; Léger J; Lortat-Jacob S; Nicolino M; Rabl W; Toledo SP; Baş F; Gompel A; Czernichow P; Josso N
    J Clin Endocrinol Metab; 1999 Feb; 84(2):627-31. PubMed ID: 10022428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gonadal dysgenesis without adrenal insufficiency in a 46, XY patient heterozygous for the nonsense C16X mutation: a case of SF1 haploinsufficiency.
    Mallet D; Bretones P; Michel-Calemard L; Dijoud F; David M; Morel Y
    J Clin Endocrinol Metab; 2004 Oct; 89(10):4829-32. PubMed ID: 15472171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time course of the serum gonadotropin surge, inhibins, and anti-Müllerian hormone in normal newborn males during the first month of life.
    Bergadá I; Milani C; Bedecarrás P; Andreone L; Ropelato MG; Gottlieb S; Bergadá C; Campo S; Rey RA
    J Clin Endocrinol Metab; 2006 Oct; 91(10):4092-8. PubMed ID: 16849404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel mutation in the accessory DNA-binding domain of human steroidogenic factor 1 causes XY gonadal dysgenesis without adrenal insufficiency.
    Reuter AL; Goji K; Bingham NC; Matsuo M; Parker KL
    Eur J Endocrinol; 2007 Aug; 157(2):233-8. PubMed ID: 17656604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the tubular and interstitial functions of the testis in 46,XY patients with ambiguous genitalia.
    Stuchi-Perez EG; Lukas-Croisier C; De Castro M; Baptista MT; Ribeiro Scolfaro M; Marques-De-Faria AP; Hackel C; Maciel-Guerra AT; Guerra Júnior G
    J Pediatr Endocrinol Metab; 2000 Jun; 13(6):605-12. PubMed ID: 10905384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of androgen receptor mutation on testicular histopathology of patient having complete androgen insensitivity.
    Bukhari I; Li G; Wang L; Iqbal F; Zhang H; Zhu J; Liu H; Fang X; Al-Daghri NM; Cooke HJ; Zhang Y; Jiang X
    J Mol Histol; 2017 Jun; 48(3):159-167. PubMed ID: 28299491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel androgen receptor gene mutations in Australian patients with complete androgen insensitivity syndrome.
    MacLean HE; Ball EM; Rekaris G; Warne GL; Zajac JD
    Hum Mutat; 2004 Mar; 23(3):287. PubMed ID: 14974091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex-reversed phenotype in association with two novel mutations c.2494delA and c.T3004C in the ligand-binding domain of the androgen receptor gene.
    Galani A; Sofocleous C; Karahaliou F; Papathanasiou A; Kitsiou-Tzeli S; Kalpini-Mavrou A
    Fertil Steril; 2008 Nov; 90(5):2008.e1-4. PubMed ID: 18342859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AR and SRD5A2 gene mutations in a series of 51 Turkish 46,XY DSD children with a clinical diagnosis of androgen insensitivity.
    Akcay T; Fernandez-Cancio M; Turan S; Güran T; Audi L; Bereket A
    Andrology; 2014 Jul; 2(4):572-8. PubMed ID: 24737579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in the amino-terminal domain of the human androgen receptor may be associated with partial androgen insensitivity and impaired transactivation in vitro.
    Holterhus PM; Werner R; Struve D; Hauffa BP; Schroeder C; Hiort O
    Exp Clin Endocrinol Diabetes; 2005 Sep; 113(8):457-63. PubMed ID: 16151980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel mutation (c.T3816 > C) in the androgen receptor gene in a 46,XY female patient with androgen insensitivity syndrome.
    Helszer Z; Dmochowska A; Borkowska E; Moczulska H; Słowikowska-Hilczer J; Pietrusiński M; Jędrzejczyk S; Kałużewski B
    Endokrynol Pol; 2013; 64(5):398-402. PubMed ID: 24186597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel point mutation in the splice donor site of exon-intron junction 6 of the androgen receptor gene in a patient with partial androgen insensitivity syndrome.
    Sammarco I; Grimaldi P; Rossi P; Cappa M; Moretti C; Frajese G; Geremia R
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3256-61. PubMed ID: 10999818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human androgen insensitivity due to point mutations encoding amino acid substitutions in the androgen receptor steroid-binding domain.
    Murono K; Mendonca BB; Arnhold IJ; Rigon AC; Migeon CJ; Brown TR
    Hum Mutat; 1995; 6(2):152-62. PubMed ID: 7581399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel (60%) and recurrent (40%) androgen receptor gene mutations in a series of 59 patients with a 46,XY disorder of sex development.
    Audi L; Fernández-Cancio M; Carrascosa A; Andaluz P; Torán N; Piró C; Vilaró E; Vicens-Calvet E; Gussinyé M; Albisu MA; Yeste D; Clemente M; Hernández de la Calle I; Del Campo M; Vendrell T; Blanco A; Martínez-Mora J; Granada ML; Salinas I; Forn J; Calaf J; Angerri O; Martínez-Sopena MJ; Del Valle J; García E; Gracia-Bouthelier R; Lapunzina P; Mayayo E; Labarta JI; Lledó G; Sánchez Del Pozo J; Arroyo J; Pérez-Aytes A; Beneyto M; Segura A; Borrás V; Gabau E; Caimarí M; Rodríguez A; Martínez-Aedo MJ; Carrera M; Castaño L; Andrade M; Bermúdez de la Vega JA;
    J Clin Endocrinol Metab; 2010 Apr; 95(4):1876-88. PubMed ID: 20150575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.